Structure Therapeutics Inc. IPO Research Information

Structure Therapeutics Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Structure Therapeutics Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Structure Therapeutics Inc.	GPCR - NASDAQ	$13.00-$15.00	$15.00	$25.00	10.7 million	2/3/2023
Underwriter(s): Jefferies, SVB Securities, Guggenheim Securities, BMO Capital Markets
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2023-01-12 Terms Added 2023-01-30

Structure Therapeutics Inc. Quote & Chart - Click for current quote - GPCR

About Structure Therapeutics Inc. (adapted from Structure Therapeutics Inc. prospectus):
They are a clinical stage global biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "GPCR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.